While previous research primarily focused on T2D or obesity-specific populations, our study specifically examines therapeutic implications for MASLD patients, addressing a critical knowledge gap regarding the benefits of combination therapy on various clinical endpoints including all-cause hospitalization, all-cause mortality, MAKE, and MALO in this population
Why Understanding Your Bodys Changes Matters The truth is, your body is operating differently than it did before the menopause transition began
eClinicalMedicine 74 , 102726 (2024)
If youre weighing stronger weight loss against lower monthly cost, our detailed Mounjaro vs Ozempic in India guide breaks down which patient profile tends to benefit more from each option
Genetic predispositions in the GIPR, FTO, and MC4R genes influence medication responsiveness